Eli Lilly misses 2024 revenue estimate by $400m monthlywealthstream
Eli Lilly has announced a $400m reduction in its 2024 revenue forecast, marking a 3% shortfall from its October 2024 guidance. The revised outlook, discussed at the JP Morgan Healthcare Conference 2025 on 14 January, has been attributed to stocking levels and unexpected market dynamics in Q4 2024 in the diabetes glucagon-like peptide-1 receptor agonist […]
Eli Lilly misses 2024 revenue estimate by $400m monthlywealthstream Read More »